Form 4: Pulse Biosciences Director Robert Duggan Increases Stake

Pulse Biosciences Director and 10% owner Robert W. Duggan acquired 192,599 shares of common stock across three transactions in September 2024 and September 2025.

Summary

• Robert W. Duggan, a Director and 10% Owner of Pulse Biosciences, Inc. (PLSE), reported the acquisition of 192,599 shares of common stock.
• The transactions occurred on September 10, 2025, September 11, 2024, and September 12, 2024.
• On September 10, 2025, 34,659 shares were purchased at a volume-weighted average price of $14.66 per share, with prices ranging from $14.51 to $14.81.
• On September 11, 2024, 12,800 shares were purchased at a volume-weighted average price of $14.77 per share, with prices ranging from $14.57 to $14.79.
• On September 12, 2024, 145,140 shares were purchased at a volume-weighted average price of $14.41 per share, with prices ranging from $13.90 to $14.75.
• Following these transactions, Mr. Duggan directly beneficially owns 47,709,140 shares of common stock.
• Additionally, Mr. Duggan indirectly beneficially owns 630,109 shares through Genius 24C Inc. and 450,189 shares through Blazon Corporation, for which he is the sole shareholder.
• The total beneficial ownership (direct and indirect) amounts to 48,789,438 shares.

Sentiment

Score: 8

Explanation: The significant purchases by a director and 10% owner indicate strong insider confidence in the company's future performance and valuation.

Positives

• Significant insider buying by a Director and 10% owner, indicating strong confidence in the company's future prospects.
• The acquisition of 192,599 shares represents a substantial increase in direct holdings.
• Purchases were made at various price points, suggesting a belief in value across a range.

Future Outlook

N/A

Industry Context

Insider purchases, especially by significant shareholders and directors, are often interpreted by the market as a positive signal, suggesting that those with the most intimate knowledge of the company believe its stock is undervalued or that significant positive developments are anticipated. This can sometimes precede periods of stock price appreciation.

Related Party Transactions

• Robert W. Duggan indirectly holds 630,109 shares through Genius 24C Inc. and 450,189 shares through Blazon Corporation, both of which he is the sole shareholder.

Stakeholder Impact

• Shareholders may view the significant insider buying as a positive indicator of management's confidence, potentially leading to increased investor interest and positive sentiment.
• The increased stake by a major shareholder could strengthen corporate governance by aligning management and shareholder interests more closely.

Key Dates

Recommendation

The substantial purchases by a Director and 10% owner, Robert W. Duggan, signal strong insider confidence in Pulse Biosciences' future prospects. Such significant insider buying often suggests that the company's stock is undervalued or that positive developments are expected, making it a compelling 'buy' signal for investors.

Keywords

Pulse Biosciences, PLSE, Robert W. Duggan, Insider Buying, Form 4, Stock Purchase, Director, 10% Owner, Beneficial Ownership